4//SEC Filing
POTTI RAM 4
Accession 0001053369-13-000034
CIK 0001053369other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 3:07 PM ET
Size
18.2 KB
Accession
0001053369-13-000034
Insider Transaction Report
Form 4
POTTI RAM
Director10% Owner
Transactions
- Conversion
Common Stock
2013-04-26+8,230,453→ 24,668,546 total(indirect: see footnote) - Other
Common Stock
2013-04-29$0.04/sh−13,367,481$493,260→ 15,626,892 total(indirect: see footnote) - Disposition to Issuer
Common Stock
2013-04-25$0.08/sh−150,000$12,000→ 16,682,019 total(indirect: see footnote) - Conversion
Series E Convertible Preferred Stock
2013-04-26$1000.00/sh−200$200,000→ 1,600 total(indirect: see footnote)Exercise: $0.02From: 2013-04-26→ Common Stock (8,230,453 underlying) - Disposition to Issuer
Common Stock
2013-04-26$0.08/sh−243,926$19,563→ 16,438,093 total(indirect: see footnote) - Disposition to Issuer
Common Stock
2013-04-29$0.08/sh−130,000$10,400→ 24,538,546 total(indirect: see footnote) - Other
Warrants
2001-04-26−13,272,999→ 26,272,001 total(indirect: see footnote)Exercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (13,272,999 underlying)
Footnotes (10)
- [F1]Ram Potti is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer.
- [F10]N/A
- [F2]Of the 16,682,019 shares of common stock, 14,910,666 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person.
- [F3]Of the 16,438,093 shares of common stock, 14,666,740 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person
- [F4]Of the 24,668,546 shares of common stock, 22,897,193 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person
- [F5]Of the 24,538,546 shares of common stock, 22,767,193 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person
- [F6]Of the 15,626,892 shares of common stock, 9,399,712 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person
- [F7]Conversion of Series E Preferred Stock of issuer at the rate of approximately 41,152.26 shares of common for each share of such preferred stock.
- [F8]Disposition of shares to its members
- [F9]Disposition of warrants to its members
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeother
Related Parties
1- filerCIK 0001465824
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 3:07 PM ET
- Size
- 18.2 KB